$2.58
0.104.25%
Last update: Oct 28, 2:36 PM
Sana Biotechnology Inc (SANA) Stock Price, Quote, News & History
SANANASDAQ
Kailera Therapeutics prices $625 million IPO, advances GLP-1 obesity pipeline as trial data highlights oral ribupatide weight loss results.
You can purchase shares of Sana Biotechnology (NASDAQ:SANA) through any online brokerage.
Other companies in Sana Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Sana Biotechnology has a consensus price target of $7.90.
The stock price for Sana Biotechnology (NASDAQ: SANA) is $2.575 last updated October 28, 2026 at 2:36 PM EDT.
There are no upcoming dividends for Sana Biotechnology.
Sana Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Sana Biotechnology.
Sana Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet...
